| 1 |
34958348 | Differential Potency of Venlafaxine, Paroxetine, and Atomoxetine to Inhibit Serotonin and Norepinephrine Reuptake in Patients With Major Depressive Disorder. | 2022 Apr 19 |
2 |
| 2 |
35053371 | Sodium Binding Stabilizes the Outward-Open State of SERT by Limiting Bundle Domain Motions. | 2022 Jan 12 |
2 |
| 3 |
35090865 | Multiple Transport Mechanisms Involved in the Intestinal Absorption of Metformin: Impact on the Nonlinear Absorption Kinetics. | 2022 May |
1 |
| 4 |
34867196 | A Novel Biotinylated Homotryptamine Derivative for Quantum Dot Imaging of Serotonin Transporter in Live Cells. | 2021 |
1 |
| 5 |
31634334 | Modification of the association between paroxetine serum concentration and SERT-occupancy by ABCB1 (P-glycoprotein) polymorphisms in major depressive disorder. | 2020 Feb |
2 |
| 6 |
32618269 | Chemical and structural investigation of the paroxetine-human serotonin transporter complex. | 2020 Jul 3 |
3 |
| 7 |
30391505 | Computation-guided analysis of paroxetine binding to hSERT reveals functionally important structural elements and dynamics. | 2019 Dec 15 |
3 |
| 8 |
31424193 | A Novel Bromine-Containing Paroxetine Analogue Provides Mechanistic Clues for Binding Ambiguity at the Central Primary Binding Site of the Serotonin Transporter. | 2019 Sep 18 |
4 |
| 9 |
29379174 | Structural basis for recognition of diverse antidepressants by the human serotonin transporter. | 2018 Feb |
1 |
| 10 |
28910072 | Mapping the Binding Site for Escitalopram and Paroxetine in the Human Serotonin Transporter Using Genetically Encoded Photo-Cross-Linkers. | 2017 Oct 20 |
1 |
| 11 |
27049939 | X-ray structures and mechanism of the human serotonin transporter. | 2016 Apr 21 |
1 |
| 12 |
27236282 | One-step preparation of [(18)F]FPBM for PET imaging of serotonin transporter (SERT) in the brain. | 2016 Aug |
1 |
| 13 |
27244236 | Decreased sensitivity to paroxetine-induced inhibition of peripheral blood mononuclear cell growth in depressed and antidepressant treatment-resistant patients. | 2016 May 31 |
1 |
| 14 |
27738376 | Paroxetine-The Antidepressant from Hell? Probably Not, But Caution Required. | 2016 Mar 1 |
1 |
| 15 |
26253622 | Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 1, a pharmacokinetic/pharmacodynamic comparison with paroxetine in healthy men. | 2015 Oct |
1 |
| 16 |
26695939 | Thermostabilization of the Human Serotonin Transporter in an Antidepressant-Bound Conformation. | 2015 |
3 |
| 17 |
24406081 | Occupancy of serotonin transporters in the amygdala by paroxetine in association with attenuation of left amygdala activation by negative faces in major depressive disorder. | 2014 Feb 28 |
2 |
| 18 |
24578810 | Serotonin Transporter Promoter Region (5-HTTLPR) Polymorphism Is Not Associated With Paroxetine-Induced Ejaculation Delay in Dutch Men With Lifelong Premature Ejaculation. | 2014 Feb |
2 |
| 19 |
24673477 | Hybrid molecules inhibiting myeloperoxidase activity and serotonin reuptake: a possible new approach of major depressive disorders with inflammatory syndrome. | 2014 Aug |
1 |
| 20 |
24858363 | The influence of 5-HTTLPR genotype on the association between the plasma concentration and therapeutic effect of paroxetine in patients with major depressive disorder. | 2014 |
2 |
| 21 |
25258536 | Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder. | 2014 |
2 |
| 22 |
23288236 | 5-HTTLPR rs25531A > G differentially influence paroxetine and fluvoxamine antidepressant efficacy: a randomized, controlled trial. | 2013 Feb |
1 |
| 23 |
23706649 | Thermostabilisation of the serotonin transporter in a cocaine-bound conformation. | 2013 Jun 26 |
1 |
| 24 |
24138674 | The expression of platelet serotonin transporter (SERT) in human obesity. | 2013 Oct 18 |
2 |
| 25 |
22774398 | Modulation of the platelet serotonin transporter by thermal balneotherapy: a study in healthy subjects. | 2012 May |
1 |
| 26 |
21272963 | Synthesis, molecular docking and binding studies of selective serotonin transporter inhibitors. | 2011 Mar |
1 |
| 27 |
21970724 | A fluorescence displacement assay for antidepressant drug discovery based on ligand-conjugated quantum dots. | 2011 Nov 9 |
4 |
| 28 |
20006597 | Antagonists and substrates differentially regulate serotonin transporter cell surface expression in serotonergic neurons. | 2010 Mar 10 |
1 |
| 29 |
20075642 | Effects of the serotonin 1A, 2A, 2C, 3A, and 3B and serotonin transporter gene polymorphisms on the occurrence of paroxetine discontinuation syndrome. | 2010 Feb |
1 |
| 30 |
20207008 | Platelet serotonin transporter function after short-term paroxetine treatment in patients with panic disorder. | 2010 Apr 30 |
1 |
| 31 |
18563559 | Binding of paroxetine to the serotonin transporter in membranes from different cells, subcellular fractions and species. | 2009 Feb |
3 |
| 32 |
18830236 | Evidence why paroxetine dose escalation is not effective in major depressive disorder: a randomized controlled trial with assessment of serotonin transporter occupancy. | 2009 Mar |
2 |
| 33 |
19606452 | Rapid response to paroxetine is associated with plasma paroxetine levels at 4 but not 8 weeks of treatment, and is independent of serotonin transporter promoter polymorphism in Japanese depressed patients. | 2009 Aug |
1 |
| 34 |
19895766 | Drinking histories in alcohol-use-disordered youth: preliminary findings on relationships to platelet serotonin transporter expression with genotypes of the serotonin transporter. | 2009 Nov |
1 |
| 35 |
17853254 | Association study of paroxetine therapeutic response with SERT gene polymorphisms in patients with major depressive disorder. | 2008 |
1 |
| 36 |
18279474 | Serotonin transporter polymorphism and bleeding time during SSRI therapy. | 2008 May |
1 |
| 37 |
18330458 | Serotonin transporter genotype interacts with paroxetine plasma levels to influence depression treatment response in geriatric patients. | 2008 Mar |
1 |
| 38 |
18418363 | Estimates of serotonin and norepinephrine transporter inhibition in depressed patients treated with paroxetine or venlafaxine. | 2008 Dec |
4 |
| 39 |
18427983 | Epileptic seizures but not pseudoseizures are associated with decreased density of the serotonin transporter in blood platelet membranes. | 2008 Nov |
1 |
| 40 |
18451636 | Decreased density of the platelet serotonin transporter in pathological gamblers. | 2008 |
2 |
| 41 |
18502014 | Sequential serotonin and noradrenalin associated processes involved in postpartum blues. | 2008 Jul 1 |
1 |
| 42 |
18552871 | Prediction of clinical response based on pharmacokinetic/pharmacodynamic models of 5-hydroxytryptamine reuptake inhibitors in mice. | 2008 Sep |
1 |
| 43 |
18788029 | Catatonic features in major depression relieved by electroconvulsive treatment: parallel evaluation of the status of platelet serotonin transporter. | 2008 Oct |
1 |
| 44 |
18983505 | Effect of the selective serotonin reuptake inhibitor paroxetine on platelet function is modified by a SLC6A4 serotonin transporter polymorphism. | 2008 Dec |
2 |
| 45 |
19936040 | Targeting the human serotonin transporter (hSERT) with quantum dots. | 2008 Feb 22 |
1 |
| 46 |
17499240 | Allosteric effects of R- and S-citalopram on the human 5-HT transporter: evidence for distinct high- and low-affinity binding sites. | 2007 Jul 12 |
2 |
| 47 |
17709099 | Selective serotonin reuptake inhibitors--a new modality for the treatment of lymphoma/leukaemia? | 2007 Nov 1 |
1 |
| 48 |
17890444 | Pharmacological interaction between 3,4-methylenedioxymethamphetamine (ecstasy) and paroxetine: pharmacological effects and pharmacokinetics. | 2007 Dec |
1 |
| 49 |
17910821 | 3-[(Aryl)(4-fluorobenzyloxy)methyl]piperidine derivatives: high-affinity ligands for the serotonin transporter. | 2007 Oct |
1 |
| 50 |
16790074 | Alteration of serotonin transporter density and activity in fibromyalgia. | 2006 |
1 |